الفهرس 
AcknowledgementsOnly 14 pages are availabe for public view
 |  | from | 169 |  |  |
| | | from | 169 | | |
Abstract
Esophageal cancer is one of the most lethal reported malignancies and a leading cause of cancer death with a poor prognosis. It is considered as the 8th most common cancer worldwide. Surgery is the main treatment modality used especially in early stage esophageal cancer and concurrent chemo-radiotherapy adds survival benefits in locally advanced disease and is used either on definitive, neo-adjuvant or adjuvant basis. Our study was a retrospective study aimed at clinic-epidemiological study of esophageal cancer patients registered in our department in the period from January 2005 to December 2014 with evaluation of the treatment outcome and if there was any associated prognostic factor affected the survival. Our study included 171 patients with median age of 59 years and male predominance in 77.8%.Smoking was identified as a risk factor for esophageal cancer in 24% of the patients followed by Barrett’s esophagus in about 6%.